Quick Answer
NEUROONE MEDICAL TECHNOLOGIES Corp reported Net Income Loss of -$3.61 million for the year ending 2025.
- NEUROONE MEDICAL TECHNOLOGIES Corp showed an increase of +70.7% in Net Income Loss from 2024 to 2025.
- This data is from NEUROONE MEDICAL TECHNOLOGIES Corp's annual report (Form 10-K), filed with the SEC on December 17, 2025.
- XBRL data for this metric is available from 2010 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2010 to 2025), NEUROONE MEDICAL TECHNOLOGIES Corp's Net Income Loss has declined by 59,552.1%.
- Historical annual values: Fiscal year 2025: -$3.61 million | Fiscal year 2024: -$12.32 million | Fiscal year 2023: -$11.86 million | Fiscal year 2022: -$10.00 million | Fiscal year 2021: -$9.95 million | Fiscal year 2020: -$13.64 million | Fiscal year 2019: -$6.78 million | Fiscal year 2016: -$47.8 thousand | Fiscal year 2015: -$62.9 thousand | Fiscal year 2014: -$36.2 thousand | Fiscal year 2013: -$30.6 thousand | Fiscal year 2012: -$27.6 thousand | Fiscal year 2011: -$27.6 thousand | Fiscal year 2010: -$6.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: